How does FLAC.U's PB Ratio compare to its peers?

FLAC.U is good value based on its Price-To-Book Ratio (-15x) compared to the peer average (4060.1x).

How does FLAC.U's PB Ratio compare vs other companies in the US Capital Markets Industry?

FLAC.U is expensive based on its Price-To-Book Ratio (-15x) compared to the US Capital Markets industry average (-26.7x)

What is FLAC.U's PB Ratio compared to its Fair PB Ratio? This is the expected PB Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

Insufficient data to calculate FLAC.U's Price-To-Book Fair Ratio for valuation analysis.

What is the Fair Price of FLAC.U when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Insufficient data to calculate FLAC.U's fair value for valuation analysis.

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Insufficient data to show price forecast.

Frazier Lifesciences Acquisition (Nasdaq:FLAC.U) - Stock Price, News & Analysis

This company has been acquired

The company may no longer be operating, as it has been acquired. Find out why through their latest events.

FLAC.U Stock Overview

Frazier Lifesciences Acquisition Corp. does not have significant operations. More details

FLAC.U fundamental analysis
Snowflake Score
Valuation	1/6
Future Growth	0/6
Past Performance	0/6
Financial Health	3/6
Dividends	0/6

Risk Analysis

Negative shareholders equity

Makes less than USD$1m in revenue ($0)

Less than 3 years of financial data is available

Frazier Lifesciences Acquisition Corporation Competitors

TriLinc Global Impact Fund

OTCPK:TRLC

US$69.3m

ESH Acquisition

NasdaqGM:ESHA

US$156.6m

Relativity Acquisition

NasdaqGM:RACY

US$228.7m

Silvercrest Asset Management Group

NasdaqGM:SAMG

US$254.3m

Price History & Performance

Summary of all time highs, changes and price drops for Frazier Lifesciences Acquisition
Historical stock prices
Current Share Price	US$9.50
52 Week High	US$10.80
52 Week Low	US$8.07
Beta	0
11 Month Change	-7.32%
3 Month Change	-6.68%
1 Year Change	-5.19%
33 Year Change	n/a
5 Year Change	n/a
Change since IPO	-7.59%

Recent updates

Shareholder Returns

	FLAC.U	US Capital Markets	US Market
7D	0.2%	0.2%	1.0%
1Y	-5.2%	52.6%	31.4%

Return vs Industry: FLAC.U exceeded the US Capital Markets industry which returned -21.3% over the past year.

Return vs Market: FLAC.U exceeded the US Market which returned -20.4% over the past year.

Price Volatility

Is FLAC.U's price volatile compared to industry and market?
FLAC.U volatility
FLAC.U Average Weekly Movement	5.4%
Capital Markets Industry Average Movement	3.8%
Market Average Movement	6.3%
10% most volatile stocks in US Market	16.3%
10% least volatile stocks in US Market	3.1%

Stable Share Price: FLAC.U has not had significant price volatility in the past 3 months.

Volatility Over Time: FLAC.U's weekly volatility (5%) has been stable over the past year.

About the Company

Founded	Employees	CEO	Website
2020	n/a	Jamie Topper	www.frazierlifesciencesacquisition.com

Frazier Lifesciences Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or related business combination with one or more businesses or entities in the biotechnology sector. The company was incorporated in 2020 and is based in Seattle, Washington.

Frazier Lifesciences Acquisition Corporation Fundamentals Summary

How do Frazier Lifesciences Acquisition's earnings and revenue compare to its market cap?
FLAC.U fundamental statistics
Market cap	US$175.20m
Earnings (TTM)	-US$3.64m
Revenue (TTM)	n/a

0.0x

P/S Ratio

-48.1x

P/E Ratio

Is FLAC.U overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
FLAC.U income statement (TTM)
Revenue	US$0
Cost of Revenue	US$0
Gross Profit	US$0
Other Expenses	US$3.64m
Earnings	-US$3.64m

Last Reported Earnings

Sep 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)	-0.20
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	0.0%

How did FLAC.U perform over the long term?

See historical performance and comparison

Frazier Lifesciences Acquisition NasdaqCM:FLAC.U Stock Report